Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

2.51
Delayed Data
As of 11:02am ET
 +0.0501 / +2.04%
Today’s Change
2.01
Today|||52-Week Range
14.70
-34.65%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close2.46
Today’s open2.46
Day’s range2.45 - 2.54
Volume43,003
Average volume (3 months)89,345
Market cap$38.3M
Dividend yield--
Data as of 11:02am ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
AZRXAzurRx BioPharma Inc+0.08+2.50%
APOPCellect Biotechnolog...+0.14+1.79%
HSGXHistogenics Corp-0.07-3.23%
KMPHKemPharm Inc-0.05-1.32%
Data as of 11:40am ET, 10/17/2017

Financials

Last reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts